Last resort: Researchers found that many veterans are using psychedelics to treat their mental health issues.
A recent study conducted by researchers revealed that a majority of American military veterans who used psychedelics reported positive outcomes, primarily utilizing these substances for healing or self-discovery. Among 426 surveyed veterans, over 80% shared a favorable overall experience, even those who encountered serious side effects. This allowed scientists to identify a potential target audience for this controversial treatment method, as noted by News Medical.
The research published in the Journal of Psychoactive Drugs highlights the increasing interest in psychedelic therapy as a means to meet individuals' mental health needs. Many indicated they would be more inclined to seek assistance from the Department of Veterans Affairs (VA) if such therapy were available. Veterans face unique and complex mental health challenges, including high rates of post-traumatic stress disorder (PTSD), depression, and anxiety.
The lead author of the study, Alan Davis, an assistant professor at Ohio State University, emphasized that the existing mental health system often fails to address these needs, prompting veterans to explore alternative options. According to the VA, more than 17 veterans die by suicide each day, underscoring the urgent need for effective measures. Transitioning from military to civilian life, as research shows, is a period of stress for many veterans, with 44% to 72% reporting significant stress during this transition.
The survey, developed with the assistance of veteran consultants, gathered data on both psychedelic users and non-users to understand the motivations, benefits, and challenges associated with the use of these substances. Survey participants reported using substances such as psilocybin, LSD, and MDMA, with their motivations primarily being healing (69%), spiritual exploration (47.5%), and relaxation (38.7%).
Veterans who used psychedelics tended to be older, served longer, and reported more frequent instances of mental health issues compared to those who did not use psychedelics. The psychedelic experiences of participants varied widely in context: some preferred solitary experiences, while others favored group settings, often in spiritual or natural environments. Although most participants rated their experiences positively, some reported negative effects, such as flashbacks or drug dependence.
Factors associated with more favorable outcomes from such practices include sourcing psychedelics from reliable providers, adequate preparation, a sense of comfort and confidence, as well as an open approach to the experience. Co-author of the study, Mark Bates, a retired Air Force pilot and clinical psychologist, noted that understanding veteran culture is crucial for effective therapy. Civilian therapists may inadvertently weaken the therapeutic bond if they fail to appreciate the unique experiences of military life. This understanding of cultural nuances was one of the reasons the questionnaire was developed with input from veterans.
This study contributes significantly to the growing body of evidence suggesting that psychedelics may hold promise for treating mental illnesses among certain populations. However, these substances remain largely inaccessible in the U.S. due to their classification as Schedule I under the Controlled Substances Act, which limits their use to clinical trials. The authors of the study hope that such findings will encourage policy changes that allow veterans access to these treatment methods through the VA, potentially reducing the rising suicide rates among this vulnerable population.
Important! This article is based on the latest scientific and medical research and does not contradict them. The text is purely informational and does not constitute medical advice. For diagnosis, please consult a physician.